We have established and validated reference ranges for bloodwork, there is also inherent lab error and variability in people's bloodwork (hence a reference range).
People < 50 should not be having routine bloodwork, and routine blood work on annual check-ups in older patients are very easy to interpret and trend.
Early warning systems need to be proven to improve patient outcomes. We have a lot of hard-learned experience in medicine where early diagnosis = bad outcomes for patients or no improved outcomes (lead-time bias).
If an algorithm somehow suspected pancreatic cancer based on routine labs, what am I supposed to do with that information? Do I schedule every patient for an endoscopic ultrasound with its associated complication rates? Do I biopsy something? What are the complication rates of those procedures versus how many patients am I helping with this early warning system?
In some case (screening mammography, colonoscopy) demonstrably improved patient outcomes but took years to decades to gather this information. In other cases (ovarian ultrasound screening) it led to unnecessary ovary removal and harmed patients. We have to be careful about what outcomes we are measuring and not rely on 'increased diagnosis' as the end goal.